Academia-Driven, Shared Value | YHLO’s 2025 Global Core Distributors Conference Concluded Successfully
Time Posted ：2025-11-20
n November 18, 2025, YHLO’s 2025 Global Core Distributors Conference was successfully held in Düsseldorf, Germany. Under the theme “Academia-Driven, Shared Value,” the meeting brought together representatives from more than 30 core distributors worldwide. YHLO’s founder, Mr. Deming Hu, and Chairman, Mr. Kunhui Hu, led the company’s executive team to attend and discuss strategic development with partners.
View Details
YHLO Secures Approval for the World’s First sCD146 CLIA Assay
Time Posted ：2025-11-18
YHLO has obtained approval from the Guangdong Medical Products Administration for its soluble CD146 (sCD146) CLIA assay, marking a major milestone in central nervous system (CNS) disease diagnostics. YHLO is now the first company worldwide to offer an sCD146 test for cerebrospinal fluid, bringing its total CLIA assay portfolio in China to 173.
View Details
YHLO × Sanofi — Building a Type 1 Diabetes Ecosystem Together
Time Posted ：2025-11-06
YHLO joined hands with Sanofi to launch the China Type 1 Diabetes Ecosystem Co-construction Alliance during the 8th China International Import Expo
View Details
Add: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China
